Results 181 to 190 of about 3,293,378 (262)

Reclassification of Antirheumatic Agents

Clinical Immunotherapeutics, 1994
Professor John Edmonds
openaire   +2 more sources

Antirheumatic Agents

, 2012
openaire   +2 more sources

Impact of rheumatoid arthritis and biologic and targeted synthetic disease modifying antirheumatic agents on cancer risk and recurrence

Current Opinion in Rheumatology, 2021
Purpose of review Several new therapeutic drugs are now available for the management of rheumatoid arthritis (RA). Given that RA has been associated with an increased risk of certain cancers like lymphoma and lung cancer, concern remains about the safety
Namrata Singh, Christopher I. Li
semanticscholar   +1 more source

Antirheumatic agents and leukocyte recruitment

Biochemical Pharmacology, 1999
M. Parnham
openaire   +2 more sources

Characterization of pristane‐induced arthritis, a murine model of chronic disease: Response to antirheumatic agents, expression of joint cytokines, and immunopathology

Arthritis & Rheumatism, 2004
Christopher Patten, Katherine Bush, Inma Rioja, Rebecca Morgan, Paul H. Wooley, John J. Trill, Paul Life   +6 more
openalex   +2 more sources

Physicochemical characteristics of human IgG Fc fragments that expose regulatory rheumatoid factor neoepitopes and may show promise as antirheumatic agents

Biotechnology and applied biochemistry, 2019
Previously, we showed that immunoglobulin G (IgG) Fc fragments can expose neoepitopes specific to antibodies that were named regulatory rheumatoid factor (regRF). RegRF confers resistance to experimental autoimmune diseases. Immunization of rats with rat
A. Sidorov, L. Beduleva, I. Menshikov, A. Terentiev, I. Cherepanov   +4 more
semanticscholar   +1 more source

Zyn-Linker delivery of antirheumatic agents

Immunologic Research, 1994
Despite our increasing ability to manage rheumatoid arthritis through systemic medication, refractory joints require local administration of more aggressive therapy in a substantial number of patients. These studies tested whether a new class of molecules designated Zyn-Linkers could deliver and retain therapeutics in a joint. Zyn-Linkers are synthetic
B M, Ohlsson-Wilhelm, M R, McDevitt, B D, Gray, R, Lorinc, H B, McIlvain, K, Sheth, S A, Weeks, K A, Muirhead   +7 more
openaire   +2 more sources

Pulmonary Disease Due to Antirheumatic Agents

Clinics in Chest Medicine, 1990
Drug-induced lung disease presents several diagnostic and therapeutic problems to the clinician. This is especially true in the case of lung disease associated with antirheumatic agents in which pulmonary disease may be due to the underlying disorder.
R J, Zitnik, J A, Cooper
openaire   +2 more sources

[Nonsteroid antirheumatic agents].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977
It is given a short, oriented to practice survey on the at present internationally most usual non-steroidal antirheumatic drugs. Picture of effect and efficiency, side-effects, indications and contraindications of these remedies are described and compared.
openaire   +1 more source

Therapeutics of antirheumatic agents.

American journal of hospital pharmacy, 1980
Eric Boyce, Ronald P. Evens
openaire   +3 more sources